Michel De Baar | Executive Director BD&L Europe
Merck

Michel De Baar, Executive Director BD&L Europe, Merck

Michel is a business development and licensing professional with experience in all steps of business transaction processes within the global pharmaceutical, biotechnology and diagnostics industries. He holds a PhD in virology and an MBA in general business management.

Michel is currently search and evaluation lead in Europe for the global BD&L team of MSD and looks after the therapeutic areas of infectious diseases and vaccines, as well as cardio-metabolic, respiratory and immunological diseases.

Appearances:



Day 2, September 29 @ 08:40

Collaborating with external organisations: create strategic partnerships with big pharmaceutical companies

last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT

back to speakers